Editorial: The role of testosterone in women

Climacteric

Volumn 12, Issue 3, 2009, Pages 185-187

  Panay, Nick ^a   Fenton, Anna ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; TESTOSTERONE; ANDROGEN;

ANDROGEN THERAPY; BREAST CANCER; CARDIOVASCULAR DISEASE; DRUG IMPLANTATION; DRUG MECHANISM; DRUG PELLET; EDITORIAL; FEMALE; FEMALE SEXUAL DYSFUNCTION; HIRSUTISM; HORMONE SYNTHESIS; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; SEXUAL FUNCTION; UNSPECIFIED SIDE EFFECT; CONFLICT OF INTEREST; DRUG EFFECT; DRUG INDUSTRY; HORMONE SUBSTITUTION; HYPERANDROGENISM; LIBIDO; MENOPAUSE; PATIENT ATTITUDE; PHYSIOLOGY; QUALITY OF LIFE;

ANDROGENS; CONFLICT OF INTEREST; DRUG INDUSTRY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERANDROGENISM; LIBIDO; MENOPAUSE; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITY OF LIFE; TESTOSTERONE;

EID: 68949094172     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130902973227     Document Type: Editorial

References (9)

1. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: Changes with age, menopause and oophorectomy. J Clin Endocrinol Metab 2005;90:3847-3853
2. Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227-236
3. Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med 2006;166:1483-1489
4. Dimitrakakis C, Jones RA, Liu A, Bondy CA. Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy. Menopause 2004;11:531-535
5. Davis SR, Moreau M, Kroll R, et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008;359: 2005-2017
6. Panay N, Fenton A. Premature ovarian failure: A growing concern. Climacteric 2008;11:1-3
7. Montgomery JC, Appleby L, Brincat M, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987;i:297-299 (Pubitemid 17018638)
8. Shifren JL, Davis SR, Moreau M, et al. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study. Menopause 2006;13:770-779
9. Food and Drug Administration, 2004, Intrinsa (testosterone transdermal system) NDA 21-768 [online]. Available: http://www.fda.gov/ohrms/ dockets/ac/04/briefing/2004-4082B1-02-B-FDAIntrinsa- Medical-Review.pdf